Pricing Log in Create free account

MARKER THERAPEUTICS, INC. (MRKR) vs Psyence Biomedical Ltd. (PBM)

MARKER THERAPEUTICS, INC. and Psyence Biomedical Ltd. are both Biotechnology companies. MARKER THERAPEUTICS, INC. and Psyence Biomedical Ltd. are of similar size ($16.5M and $15.3M). MARKER THERAPEUTICS, INC. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Across the 10 metrics below, Psyence Biomedical Ltd. leads on 8 and MARKER THERAPEUTICS, INC. on 2.

Valuation

Metric MRKR PBM Biotechnology median
P/E n/m 0.19 8.50
P/S 4.22 n/m 9.71
P/B 1.65 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.82 0.64
EV/Sales 1.89 n/m 9.21
Earnings yield (39.42%) 534.77% (33.15%)
Free cash flow yield (109.02%) (807.70%) (25.50%)

Profitability

Metric MRKR PBM Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.87%) (23.52%) (56.36%)
Return on assets (59.33%) (6.74%) (48.04%)
Return on invested capital (566.75%) 0.00% 0.00%

Growth

Metric MRKR PBM Biotechnology median
Revenue growth (TTM) (27.83%) — 6.02%
EPS growth (last fiscal year) 33.61% (138.35%) 30.26%
Revenue growth, 5-year CAGR 50.02% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRKR PBM Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 6.03 8.09 4.72
Net debt to EBITDA 1.32 1.20 0.96

Dividend

Metric MRKR PBM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MRKR PBM Biotechnology median
Market cap 15.34m 16.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack